Published in Biomed Res Int on April 29, 2014
Analysis of liver-directed therapies in U.S. cancer patients. Curr Oncol (2015) 0.75
Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma. Curr Probl Diagn Radiol (2017) 0.75
Hepatocellular carcinoma. Lancet (2012) 18.09
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg (2006) 5.65
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg (2010) 4.75
Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology (2002) 3.16
Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg (1976) 2.96
Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol (2007) 2.83
American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol (2009) 2.52
Principles of and advances in percutaneous ablation. Radiology (2011) 2.44
International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2011) 2.40
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology (2009) 2.25
Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol (2009) 2.17
Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology (2012) 2.16
Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg (2008) 2.09
Solitary colorectal liver metastasis: resection determines outcome. Arch Surg (2006) 2.06
Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol (2012) 1.99
Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol (2010) 1.84
High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg (2011) 1.79
Irreversible electroporation for the ablation of liver tumors: are we there yet? Arch Surg (2012) 1.74
Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg (2012) 1.71
Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg (2013) 1.58
Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma. Ann Surg (2013) 1.51
Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol (2009) 1.50
Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44
[Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial]. Zhonghua Yi Xue Za Zhi (2006) 1.43
Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology (2005) 1.40
Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev (2012) 1.37
Microwave tissue ablation: biophysics, technology, and applications. Crit Rev Biomed Eng (2010) 1.34
Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial. HPB (Oxford) (2007) 1.33
Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated. PLoS One (2013) 1.32
World survey on the complications of hepatic and prostate cryotherapy. World J Surg (1999) 1.25
Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer (2000) 1.23
Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology (1996) 1.21
Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol (2003) 1.18
Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer (2009) 1.18
Percutaneous ablation of peribiliary tumors with irreversible electroporation. J Vasc Interv Radiol (2013) 1.16
Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. Technol Cancer Res Treat (2013) 1.13
Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg (2009) 1.12
Treatment of colorectal liver metastases. World J Surg Oncol (2011) 1.04
Interventional oncologic approaches to liver metastases. Radiology (2013) 1.03
Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. J Gastroenterol Hepatol (2013) 1.02
Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases. Abdom Imaging (2001) 1.00
Cryotherapy for primary liver cancer. Semin Surg Oncol (1998) 1.00
Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis. Am J Surg (2009) 0.99
Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors. Liver Int (2012) 0.98
Hepatocellular carcinoma downstaging in liver transplantation. Transplant Proc (2012) 0.98
Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma. Ultrasound Med Biol (2011) 0.96
[Comparison of effects of percutaneous radiofrequency ablation and surgical resection on small hepatocellular carcinoma]. Zhonghua Yi Xue Za Zhi (2005) 0.95
The place of downstaging for hepatocellular carcinoma. J Hepatol (2010) 0.95
Five-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapy. Endoscopy (2005) 0.95
Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol (2013) 0.95
Pain analysis in patients with hepatocellular carcinoma: irreversible electroporation versus radiofrequency ablation-initial observations. Cardiovasc Intervent Radiol (2012) 0.92
Efficacy of surgical microwave therapy in patients with unresectable hepatocellular carcinoma. Ann Surg Oncol (2011) 0.91
Percutaneous cryosurgery for the treatment of hepatic colorectal metastases. World J Gastroenterol (2008) 0.90
Percutaneous irreversible electroporation (IRE) of hepatic malignant tumours: contrast-enhanced ultrasound (CEUS) findings. Clin Hemorheol Microcirc (2012) 0.89
Thoracoscopy-assisted magnetic resonance guided microwave coagulation therapy for hepatic tumors. Am J Surg (2008) 0.86
Percutaneous alcohol ablation for liver metastasis. Semin Oncol (2002) 0.85
The current role of minimally invasive therapies in the management of liver tumors. Abdom Imaging (2011) 0.85
Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation. J Vasc Interv Radiol (2006) 0.85
High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients. World J Gastroenterol (2013) 0.85
Colorectal cancer liver metastases: long-term survival and progression-free survival after thermal ablation using magnetic resonance-guided laser-induced interstitial thermotherapy in 594 patients: analysis of prognostic factors. Invest Radiol (2014) 0.85
Cryoablation of malignant liver tumors: results of a single center study. Hepatobiliary Pancreat Dis Int (2005) 0.84
MR-guided interstitial laser thermotherapy of colorectal liver metastases: efficiency, safety and patient survival. Eur J Med Res (2007) 0.83
Recurrence and survival outcomes after hepatic resection with or without cryotherapy for liver metastases from colorectal carcinoma. Ann Surg Oncol (2007) 0.83
Clinical experience with cryosurgery for advanced hepatobiliary tumors. J Surg Res (1998) 0.82
Liver resection or cryotherapy for colorectal liver metastases: a prospective case control study. Int J Colorectal Dis (2005) 0.80
Microwave coagulation for liver metastases. Cochrane Database Syst Rev (2013) 0.80
[Transarterial oily chemoembolization combined with interstitial laser thermotherapy for treatment of hepatocellular carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao (2007) 0.78
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. Cochrane Database Syst Rev (2009) 0.78
Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation. Ann Transplant (2012) 0.77
Is cryosurgical ablation appropriate for treating hepatocellular cancer? Arch Surg (1997) 0.77
Surgical therapy for hepatocellular carcinoma: formulating a rational approach. J Clin Gastroenterol (2013) 0.76
Percutaneous ethanol injection for liver metastases. Cochrane Database Syst Rev (2013) 0.76
[Therapeutic effects of sorafenib combined with transcatheter arterial chemoembolization and microwave ablation on postsurgical recurrent hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi (2012) 0.76
[Surgical treatment for colorectal liver metastases--results of multi-institute study for effects of radical hepatectomy]. Gan To Kagaku Ryoho (2004) 0.76